EOLS – Evolus, Inc.
Evolus, Inc. Common StockEOLS
$6.25Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $403,960,448.00
EPSttm : -0.97
Evolus, Inc. Common Stock
$6.25
2.88%$0.185Float Short %
22.92
Margin Of Safety %
Put/Call OI Ratio
0.61
EPS Next Q Diff
0.37
EPS Last/This Y
0.26
EPS This/Next Y
0.69
Price
6.43
Target Price
18.83
Analyst Recom
1.29
Performance Q
-30.56
Relative Volume
0.6
Beta
0.97
Ticker: EOLS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | EOLS | 7.62 | 1.27 | 0.37 | 18939 |
| 2025-09-09 | EOLS | 7.41 | 1.25 | 0.50 | 19071 |
| 2025-09-10 | EOLS | 7.35 | 1.25 | 0.01 | 19075 |
| 2025-09-11 | EOLS | 7.51 | 1.25 | 0.04 | 19040 |
| 2025-09-12 | EOLS | 7.2 | 1.25 | 0.01 | 19089 |
| 2025-09-15 | EOLS | 6.63 | 1.22 | 0.83 | 19253 |
| 2025-09-16 | EOLS | 6.51 | 1.22 | 0.02 | 19279 |
| 2025-09-17 | EOLS | 6.52 | 1.168378050127 | 0.018518518518519 | 19639 |
| 2025-09-18 | EOLS | 6.41 | 1.14 | 0.00 | 19635 |
| 2025-09-22 | EOLS | 6.31 | 1.20 | 0.57 | 19205 |
| 2025-09-23 | EOLS | 6.2 | 0.63 | 0.00 | 14238 |
| 2025-09-24 | EOLS | 6.08 | 0.63 | 1.25 | 14240 |
| 2025-09-25 | EOLS | 5.97 | 0.63 | 0.57 | 14250 |
| 2025-09-26 | EOLS | 6.03 | 0.63 | 1.00 | 14595 |
| 2025-09-29 | EOLS | 6.15 | 0.63 | 0.14 | 14619 |
| 2025-09-30 | EOLS | 6.1 | 0.63 | 0.00 | 14672 |
| 2025-10-01 | EOLS | 6.15 | 0.63 | 0.00 | 14676 |
| 2025-10-02 | EOLS | 6.24 | 0.62 | 0.00 | 14680 |
| 2025-10-03 | EOLS | 6.49 | 0.62 | 0.05 | 14809 |
| 2025-10-06 | EOLS | 6.43 | 0.61 | 0.00 | 14944 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | EOLS | 7.61 | 12.3 | 62.2 | -0.55 |
| 2025-09-09 | EOLS | 7.41 | 12.3 | 61.8 | -0.55 |
| 2025-09-10 | EOLS | 7.34 | 12.3 | 62.2 | -0.55 |
| 2025-09-11 | EOLS | 7.51 | 12.3 | 62.7 | -0.55 |
| 2025-09-12 | EOLS | 7.20 | 12.3 | 61.6 | -0.55 |
| 2025-09-15 | EOLS | 6.62 | 12.3 | 60.9 | -0.55 |
| 2025-09-16 | EOLS | 6.52 | 12.3 | 62.0 | -0.55 |
| 2025-09-17 | EOLS | 6.53 | 12.3 | 62.3 | -0.55 |
| 2025-09-18 | EOLS | 6.41 | 12.3 | 62.0 | -0.55 |
| 2025-09-19 | EOLS | 6.27 | 12.3 | 61.9 | -0.55 |
| 2025-09-22 | EOLS | 6.31 | 12.3 | 62.4 | -0.55 |
| 2025-09-23 | EOLS | 6.20 | 12.3 | 62.0 | -0.55 |
| 2025-09-24 | EOLS | 6.08 | 12.3 | 62.0 | -0.55 |
| 2025-09-25 | EOLS | 5.98 | 12.3 | 62.0 | -0.55 |
| 2025-09-26 | EOLS | 5.99 | 12.3 | 62.3 | -0.55 |
| 2025-09-29 | EOLS | 6.15 | 12.3 | 62.8 | -0.55 |
| 2025-09-30 | EOLS | 6.15 | 12.3 | 62.4 | -0.55 |
| 2025-10-01 | EOLS | 6.14 | 12.3 | 62.3 | -0.55 |
| 2025-10-02 | EOLS | 6.24 | 12.3 | 62.6 | -0.55 |
| 2025-10-03 | EOLS | 6.50 | 12.3 | 63.1 | -0.55 |
| 2025-10-06 | EOLS | 6.43 | 12.3 | 62.9 | -0.55 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | EOLS | -1.93 | 9.35 | 21.02 |
| 2025-09-09 | EOLS | -1.93 | 9.35 | 21.02 |
| 2025-09-10 | EOLS | -1.93 | 9.35 | 21.02 |
| 2025-09-11 | EOLS | -1.93 | 9.35 | 22.89 |
| 2025-09-12 | EOLS | -1.93 | 9.35 | 22.89 |
| 2025-09-15 | EOLS | -1.84 | 9.27 | 22.89 |
| 2025-09-16 | EOLS | -1.84 | 9.27 | 22.89 |
| 2025-09-17 | EOLS | -1.84 | 9.27 | 22.89 |
| 2025-09-18 | EOLS | -1.84 | 9.27 | 22.89 |
| 2025-09-19 | EOLS | -1.84 | 9.27 | 22.89 |
| 2025-09-22 | EOLS | -0.83 | 9.27 | 22.86 |
| 2025-09-23 | EOLS | -0.83 | 9.27 | 22.86 |
| 2025-09-24 | EOLS | -0.83 | 9.27 | 22.86 |
| 2025-09-25 | EOLS | -0.83 | 9.27 | 22.92 |
| 2025-09-26 | EOLS | -0.83 | 9.27 | 22.92 |
| 2025-09-29 | EOLS | -0.79 | 9.27 | 22.92 |
| 2025-09-30 | EOLS | -0.79 | 9.27 | 22.92 |
| 2025-10-01 | EOLS | -0.79 | 9.27 | 22.92 |
| 2025-10-02 | EOLS | -0.79 | 9.27 | 22.92 |
| 2025-10-03 | EOLS | -0.79 | 9.27 | 22.92 |
| 2025-10-06 | EOLS | -0.79 | 5.26 | 22.92 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.3
Avg. EPS Est. Current Quarter
-0.16
Avg. EPS Est. Next Quarter
0.07
Insider Transactions
-0.79
Institutional Transactions
5.26
Beta
0.97
Average Sales Estimate Current Quarter
67
Average Sales Estimate Next Quarter
91
Fair Value
Quality Score
31
Growth Score
52
Sentiment Score
70
Actual DrawDown %
63.9
Max Drawdown 5-Year %
-68.4
Target Price
18.83
P/E
Forward P/E
22.61
PEG
P/S
1.5
P/B
P/Free Cash Flow
EPS
-0.97
Average EPS Est. Cur. Y
-0.55
EPS Next Y. (Est.)
0.14
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-22.31
Relative Volume
0.6
Return on Equity vs Sector %
307.3
Return on Equity vs Industry %
324.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
62.9
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 394
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading